secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inmune Bio, Inc. (INMB)
CIK:        0001711754
Form:       8-K
Filed at:   2025-12-03T23:59:59+00:00
Accession:  0001213900-25-117828
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INmune Bio corrects CEO/CFO base salaries and CEO option grant in employment agreements
--------------------------------------------------------------------------------

- CEO David Moss base salary corrected to $454,000 per annum; option grant corrected to 750,000 shares.
- CFO Cory Ellspermann base salary corrected to $240,000 per annum.
- Amendments effective retroactively to November 26, 2025, to fix clerical errors in original agreements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711754/000121390025117828/0001213900-25-117828-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711754/000121390025117828/ea0268270-8k_inmune.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-117828

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer